Batch assay method evaluation of cytoplasmic estrogen receptor. Relative immunity of hydroxylapatite method from errors of measurement

Utilizing a refined hydroxylapatite assay technique for the measurement of cytoplasmic estradiol- 17 β binding in both immature rat uterine tissue and human breast cancer biopsies, we compare the specificity and sensitivity of our method to those capabilities of previously reported batch techniques...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cancer 1980-11, Vol.16 (11), p.1495-1502
Hauptverfasser: Rosner, Anthony L., Teman, Glenn H., Bray, Caryn L., Burstein, Nelson A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1502
container_issue 11
container_start_page 1495
container_title European journal of cancer
container_volume 16
creator Rosner, Anthony L.
Teman, Glenn H.
Bray, Caryn L.
Burstein, Nelson A.
description Utilizing a refined hydroxylapatite assay technique for the measurement of cytoplasmic estradiol- 17 β binding in both immature rat uterine tissue and human breast cancer biopsies, we compare the specificity and sensitivity of our method to those capabilities of previously reported batch techniques which prescribe either (i) adsorption of free estradiol to dextran-coated charcoal; or (ii) precipitation of cytosol by protamine sulfate, followed by the incubation of the residue with ligand. Compared to alternative methods, the hydroxylapatite assay yields (a) no losses of specific estrogen-binding activities over a wide range of concentrations of cytosol protein, (b) saturation plots which suggest more uniformity in the specific estradiol-binding sites being measured, (c) no alteration in the recovery of estradiol-binding activity with variations of the time of adsorption, and (d) specific binding values that are not significantly influenced by the presence or absence of bovine serum albumin, a nonspecific, nonsaturable estradiol-binding protein.
doi_str_mv 10.1016/0014-2964(80)90061-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75506056</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0014296480900614</els_id><sourcerecordid>75506056</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-c2b939a6e4b8dff13eb0b0da712e04f990e746bc8da1a4d38ff281d60ca003493</originalsourceid><addsrcrecordid>eNp9kMtq3TAQhrVoSdO0b9CAVqFZOB3J8m0TaEJvECiUdi1kaZSjYFmOJB_iF-hz1-45zbKrgfkvw3yEvGNwxYDVHwCYKHhXi_ctXHYANSvEC3L6vH5FXqf0AMBbUfETctJw3gguTsnvG5X1jqqU1EI95l0wFPdqmFV2YaTBUr3kMA0qeacpphzDPY40osYph3hFf-CwWvdInffz6PKyZXaLieFpGdS0ahn_FdsYPMUYQ0yby6NKc0SPY35DXlo1JHx7nGfk1-dPP2-_Fnffv3y7_XhX6LJqcqF535WdqlH0rbGWldhDD0Y1jCMI23WAjah73RrFlDBlay1vmalBK4BSdOUZuTj0TjE8zus70rukcRjUiGFOsqkqqKGqV6M4GHUMKUW0corOq7hIBnJDLje2cmMrW5B_kUuxxs6P_XPv0TyHjrxX_fqg4_rk3mGUSTscNRq3Is3SBPf_A38Ayr2WRQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75506056</pqid></control><display><type>article</type><title>Batch assay method evaluation of cytoplasmic estrogen receptor. Relative immunity of hydroxylapatite method from errors of measurement</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Rosner, Anthony L. ; Teman, Glenn H. ; Bray, Caryn L. ; Burstein, Nelson A.</creator><creatorcontrib>Rosner, Anthony L. ; Teman, Glenn H. ; Bray, Caryn L. ; Burstein, Nelson A.</creatorcontrib><description>Utilizing a refined hydroxylapatite assay technique for the measurement of cytoplasmic estradiol- 17 β binding in both immature rat uterine tissue and human breast cancer biopsies, we compare the specificity and sensitivity of our method to those capabilities of previously reported batch techniques which prescribe either (i) adsorption of free estradiol to dextran-coated charcoal; or (ii) precipitation of cytosol by protamine sulfate, followed by the incubation of the residue with ligand. Compared to alternative methods, the hydroxylapatite assay yields (a) no losses of specific estrogen-binding activities over a wide range of concentrations of cytosol protein, (b) saturation plots which suggest more uniformity in the specific estradiol-binding sites being measured, (c) no alteration in the recovery of estradiol-binding activity with variations of the time of adsorption, and (d) specific binding values that are not significantly influenced by the presence or absence of bovine serum albumin, a nonspecific, nonsaturable estradiol-binding protein.</description><identifier>ISSN: 0014-2964</identifier><identifier>DOI: 10.1016/0014-2964(80)90061-4</identifier><identifier>PMID: 7227424</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Breast Neoplasms - analysis ; Centrifugation, Density Gradient ; Cytoplasm - analysis ; Cytosol - analysis ; Estradiol ; Female ; Humans ; Hydroxyapatites ; Methods ; Rats ; Receptors, Estrogen - analysis ; Receptors, Estrogen - metabolism ; Uterus - analysis</subject><ispartof>European journal of cancer, 1980-11, Vol.16 (11), p.1495-1502</ispartof><rights>1980</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-c2b939a6e4b8dff13eb0b0da712e04f990e746bc8da1a4d38ff281d60ca003493</citedby><cites>FETCH-LOGICAL-c357t-c2b939a6e4b8dff13eb0b0da712e04f990e746bc8da1a4d38ff281d60ca003493</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7227424$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rosner, Anthony L.</creatorcontrib><creatorcontrib>Teman, Glenn H.</creatorcontrib><creatorcontrib>Bray, Caryn L.</creatorcontrib><creatorcontrib>Burstein, Nelson A.</creatorcontrib><title>Batch assay method evaluation of cytoplasmic estrogen receptor. Relative immunity of hydroxylapatite method from errors of measurement</title><title>European journal of cancer</title><addtitle>Eur J Cancer</addtitle><description>Utilizing a refined hydroxylapatite assay technique for the measurement of cytoplasmic estradiol- 17 β binding in both immature rat uterine tissue and human breast cancer biopsies, we compare the specificity and sensitivity of our method to those capabilities of previously reported batch techniques which prescribe either (i) adsorption of free estradiol to dextran-coated charcoal; or (ii) precipitation of cytosol by protamine sulfate, followed by the incubation of the residue with ligand. Compared to alternative methods, the hydroxylapatite assay yields (a) no losses of specific estrogen-binding activities over a wide range of concentrations of cytosol protein, (b) saturation plots which suggest more uniformity in the specific estradiol-binding sites being measured, (c) no alteration in the recovery of estradiol-binding activity with variations of the time of adsorption, and (d) specific binding values that are not significantly influenced by the presence or absence of bovine serum albumin, a nonspecific, nonsaturable estradiol-binding protein.</description><subject>Animals</subject><subject>Breast Neoplasms - analysis</subject><subject>Centrifugation, Density Gradient</subject><subject>Cytoplasm - analysis</subject><subject>Cytosol - analysis</subject><subject>Estradiol</subject><subject>Female</subject><subject>Humans</subject><subject>Hydroxyapatites</subject><subject>Methods</subject><subject>Rats</subject><subject>Receptors, Estrogen - analysis</subject><subject>Receptors, Estrogen - metabolism</subject><subject>Uterus - analysis</subject><issn>0014-2964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1980</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtq3TAQhrVoSdO0b9CAVqFZOB3J8m0TaEJvECiUdi1kaZSjYFmOJB_iF-hz1-45zbKrgfkvw3yEvGNwxYDVHwCYKHhXi_ctXHYANSvEC3L6vH5FXqf0AMBbUfETctJw3gguTsnvG5X1jqqU1EI95l0wFPdqmFV2YaTBUr3kMA0qeacpphzDPY40osYph3hFf-CwWvdInffz6PKyZXaLieFpGdS0ahn_FdsYPMUYQ0yby6NKc0SPY35DXlo1JHx7nGfk1-dPP2-_Fnffv3y7_XhX6LJqcqF535WdqlH0rbGWldhDD0Y1jCMI23WAjah73RrFlDBlay1vmalBK4BSdOUZuTj0TjE8zus70rukcRjUiGFOsqkqqKGqV6M4GHUMKUW0corOq7hIBnJDLje2cmMrW5B_kUuxxs6P_XPv0TyHjrxX_fqg4_rk3mGUSTscNRq3Is3SBPf_A38Ayr2WRQ</recordid><startdate>198011</startdate><enddate>198011</enddate><creator>Rosner, Anthony L.</creator><creator>Teman, Glenn H.</creator><creator>Bray, Caryn L.</creator><creator>Burstein, Nelson A.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198011</creationdate><title>Batch assay method evaluation of cytoplasmic estrogen receptor. Relative immunity of hydroxylapatite method from errors of measurement</title><author>Rosner, Anthony L. ; Teman, Glenn H. ; Bray, Caryn L. ; Burstein, Nelson A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-c2b939a6e4b8dff13eb0b0da712e04f990e746bc8da1a4d38ff281d60ca003493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1980</creationdate><topic>Animals</topic><topic>Breast Neoplasms - analysis</topic><topic>Centrifugation, Density Gradient</topic><topic>Cytoplasm - analysis</topic><topic>Cytosol - analysis</topic><topic>Estradiol</topic><topic>Female</topic><topic>Humans</topic><topic>Hydroxyapatites</topic><topic>Methods</topic><topic>Rats</topic><topic>Receptors, Estrogen - analysis</topic><topic>Receptors, Estrogen - metabolism</topic><topic>Uterus - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rosner, Anthony L.</creatorcontrib><creatorcontrib>Teman, Glenn H.</creatorcontrib><creatorcontrib>Bray, Caryn L.</creatorcontrib><creatorcontrib>Burstein, Nelson A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rosner, Anthony L.</au><au>Teman, Glenn H.</au><au>Bray, Caryn L.</au><au>Burstein, Nelson A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Batch assay method evaluation of cytoplasmic estrogen receptor. Relative immunity of hydroxylapatite method from errors of measurement</atitle><jtitle>European journal of cancer</jtitle><addtitle>Eur J Cancer</addtitle><date>1980-11</date><risdate>1980</risdate><volume>16</volume><issue>11</issue><spage>1495</spage><epage>1502</epage><pages>1495-1502</pages><issn>0014-2964</issn><abstract>Utilizing a refined hydroxylapatite assay technique for the measurement of cytoplasmic estradiol- 17 β binding in both immature rat uterine tissue and human breast cancer biopsies, we compare the specificity and sensitivity of our method to those capabilities of previously reported batch techniques which prescribe either (i) adsorption of free estradiol to dextran-coated charcoal; or (ii) precipitation of cytosol by protamine sulfate, followed by the incubation of the residue with ligand. Compared to alternative methods, the hydroxylapatite assay yields (a) no losses of specific estrogen-binding activities over a wide range of concentrations of cytosol protein, (b) saturation plots which suggest more uniformity in the specific estradiol-binding sites being measured, (c) no alteration in the recovery of estradiol-binding activity with variations of the time of adsorption, and (d) specific binding values that are not significantly influenced by the presence or absence of bovine serum albumin, a nonspecific, nonsaturable estradiol-binding protein.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>7227424</pmid><doi>10.1016/0014-2964(80)90061-4</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2964
ispartof European journal of cancer, 1980-11, Vol.16 (11), p.1495-1502
issn 0014-2964
language eng
recordid cdi_proquest_miscellaneous_75506056
source MEDLINE; Alma/SFX Local Collection
subjects Animals
Breast Neoplasms - analysis
Centrifugation, Density Gradient
Cytoplasm - analysis
Cytosol - analysis
Estradiol
Female
Humans
Hydroxyapatites
Methods
Rats
Receptors, Estrogen - analysis
Receptors, Estrogen - metabolism
Uterus - analysis
title Batch assay method evaluation of cytoplasmic estrogen receptor. Relative immunity of hydroxylapatite method from errors of measurement
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T19%3A29%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Batch%20assay%20method%20evaluation%20of%20cytoplasmic%20estrogen%20receptor.%20Relative%20immunity%20of%20hydroxylapatite%20method%20from%20errors%20of%20measurement&rft.jtitle=European%20journal%20of%20cancer&rft.au=Rosner,%20Anthony%20L.&rft.date=1980-11&rft.volume=16&rft.issue=11&rft.spage=1495&rft.epage=1502&rft.pages=1495-1502&rft.issn=0014-2964&rft_id=info:doi/10.1016/0014-2964(80)90061-4&rft_dat=%3Cproquest_cross%3E75506056%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75506056&rft_id=info:pmid/7227424&rft_els_id=0014296480900614&rfr_iscdi=true